Meeder Asset Management Inc Centogene N.V. Transaction History

Meeder Asset Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.11 - $2.78 $5,697 - $14,269	-5,133 Reduced 97.38%	138 $0
Q2 2022 Aug 08, 2022	BUY	$2.06 - $4.25 $206 - $425	100 Added 1.93%	5,271 $14,000
Q1 2022 May 10, 2022	BUY	$3.3 - $5.44 $9 - $16	3 Added 0.06%	5,171 $22,000
Q4 2021 Feb 11, 2022	SELL	$4.56 - $10.56 $136 - $316	-30 Reduced 0.58%	5,168 $27,000
Q2 2021 Aug 09, 2021	BUY	$9.02 - $12.93 $31,497 - $45,151	3,492 Added 204.69%	5,198 $54,000
Q1 2021 Apr 28, 2021	BUY	$10.56 - $13.94 $18,015 - $23,781	1,706 New	1,706 $19,000
Q4 2020 Feb 09, 2021	SELL	$9.44 - $13.3 $16,104 - $22,689	-1,706 Closed	0 $0
Q3 2020 Nov 02, 2020	SELL	$9.3 - $25.16 $7,505 - $20,304	-807 Reduced 32.11%	1,706 $15,000
Q2 2020 Aug 11, 2020	SELL	$15.99 - $22.88 $13,719 - $19,631	-858 Reduced 25.45%	2,513 $58,000
Q1 2020 May 15, 2020	BUY	$9.76 - $23.8 $32,900 - $80,229	3,371 New	3,371 $67,000

33.6K

Ticker CNTG
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,081,600
Market Cap $2.98M
Description
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.